Friday, October 30, 2020
Home Tags APHEX

Tag: APHEX

Aphex BioCleanse
Superbug News - CoronaVirus Watch List

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Editor / Curator -
Biotech News

Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Editor / Curator -
Aphex BioCleanse
Biotech News

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Photos: Aphex BioCleanse Systems.

Editor / Curator -
APHX, APHEX
Biotech News

Aphex BioCleanse Systems Inc, Expands Sanitizer Production at its New Manufacturing...

Editor / Curator -
Alpex BioCleanse, Biotech Stock Review
Superbug News - CoronaVirus Watch List

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now...

Editor / Curator -
Aphex BioCleanse
Superbug News - CoronaVirus Watch List

Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.

Editor / Curator -
coronavirus stocks
Superbug News - CoronaVirus Watch List

Coronavirus Stock Mania. 800% Gain, Seen in a Single Day on...

Editor / Curator -

Latest article

Hapbee,

Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.

All News Editor / Curator -
VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
Dalarada Health, Biotech Stock Review

Dalrada Cervical Cancer Testing Kit Study.

All News Editor / Curator -
KEY TAKEAWAYS Dalrada Corp (DFCO) LIVE QUOTE
biotech stock review

Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.

All News Editor / Curator -
DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.